Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SYLVAMO CORP (SLVM)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 5
  • 1 comments

Sylvamo CEO to Host Meetings During the Truist Securities Industrials and Services Conference

Market reaction Comment Full text

TRUEBLUE, INC. (TBI)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 1
  • 1 comments

TrueBlue Earns Forbes Recognition for Temporary Staffing Excellence

Market reaction Comment Full text

EVOLV TECHNOLOGIES HOLDINGS, INC. (EVLV)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 3
  • 1 comments

Evolv eXpedite™ Achieves SAFETY Act Designation, Joining Evolv Express® as Qualified Anti-Terrorism Technology

Market reaction Comment Full text

BITGO HOLDINGS, INC. (BTGO)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 1
  • 1 comments

BitGo Holdings Named to 2026 Fortune 500 in First Year as a Public Company

Market reaction Comment Full text

GUERRILLA RF, INC. (GUER)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 3
  • 1 comments

Guerrilla RF Launches Innovative GRF5847 Linear PA Module Featuring Fully Matched 50-Ohm Interfaces and Industry-Leading Output Power

Market reaction Comment Full text

VIRTUS INVESTMENT PARTNERS, INC. (VRTS)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 1
  • 1 comments

Virtus Investment Partners Reports Preliminary May 31, 2026 Assets Under Management

Market reaction Comment Full text

NICE LTD. (NICE)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 2
  • 1 comments

NiCE Honors the Changemakers Building the Future of CX AI at NiCE World 2026

Market reaction Comment Full text

MACY''S, INC. (M)

  • Business News
  • June 10, 2026, 12:00 UTC
  • 3
  • 1 comments

Macy’s Kicks Off Summer as the Ultimate World Soccer HQ, Bringing the Global Game to Life Nationwide

Market reaction Comment Full text

FATTAL HOLDINGS (1998) LTD (FTAL)

  • Business News
  • June 10, 2026, 11:59 UTC
  • 5
  • 1 comments

Commercial papers interest 2 for the period 23.6.25–21.6.26 is 4.68447%

Market reaction Comment Full text

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

  • Business News
  • June 10, 2026, 11:47 UTC
  • 6
  • 1 comments

GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region

Market reaction Comment Full text
  • Previous
  • 2175
  • 2176
  • 2177
  • 2178
  • 2179
  • Next

Search

News categories

  • Technical Exchange News(13948)
  • Event(6229)
  • SEC News(352925)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(213800)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin